Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6AGY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $84,809
Award facts
- Contract value 100% obligated
- $84,809.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (quantity: 120) with a ceiling value of $84.8K. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the contract at its headquarters location.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at approximately $500M and valid through November 2026. The parent IDC, awarded under the SPE2DB program, authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facility supply needs worldwide. Xtandi, a branded oncology medication, represents one of many specialty pharmaceutical products within the IDC's scope. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to deliver prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AGY?
SPE2DX25F6AGY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 23, 2025.
How much is contract SPE2DX25F6AGY worth?
The government has obligated $84,809 on SPE2DX25F6AGY.
Is contract SPE2DX25F6AGY an order under another contract?
Yes. SPE2DX25F6AGY is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGY competed?
The extent of competition for SPE2DX25F6AGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award